Pembrolizumab and Cabozantinib in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma (RMHNSCC): 2-year Long Term Survival Update with Biomarker Analysis
| Autor: | Saba, N.F., Ekpenyong, A., McCook, A., Schmitt, N.C., Gross, J.H., Rudra, S.F., Stokes, W.A., Kirtane, K., Chaudhary, R., Biernacki, M., Slebos, R., Song, X., Steuer, C., Shin, D.M., Teng, Y.F., Liu, Y., Chung, C.H. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e3-e3 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|